Six-year outcomes of a phase II study of human-tissue engineered blood vessels for peripheral arterial bypass

Six-year outcomes of a phase II study of human-tissue engineered blood vessels for peripheral arterial bypass

Objective: The human acellular vessel (HAV) was evaluated for surgical bypass in a phase II study. The primary results at 24 months after implantation have been reported, and the patients will be evaluated for ≤10 years. Methods: In the present report, we have described the 6-year results of a prosp...

Full description

Bibliographic Details
Main Authors: Piotr Gutowski, MD, PhD, Malgorzata Guziewicz, MD, PhD, Marek Ilzecki, MD, PhD, Arkadiusz Kazimierczak, MD, PhD, Jeffrey H. Lawson, MD, PhD, Heather L. Prichard, PhD, Stanislaw Przywara, MD, PhD, Rabih Samad, MD, PhD, William Tente, MS, Jakub Turek, MD, Wojcieh Witkiewicz, MD, PhD, Norbert Zapotoczny, MD, Tomaz Zubilewicz, MD, PhD, Laura E. Niklason, MD, PhD
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:JVS - Vascular Science
Subjects:
Arterial reconstruction
Bioengineered blood vessel
Human acellular vessel
Long-term outcomes
Peripheral artery disease
Online Access:http://www.sciencedirect.com/science/article/pii/S2666350322000803

Internet

http://www.sciencedirect.com/science/article/pii/S2666350322000803

Similar Items